Many individual biotech stocks have performed far worse. One bright side to all of that selling is that a handful of high-quality biotech stocks are currently trading for attractive prices.
Category: Regeneron Pharmaceuticals
Drug company exec: ‘We’re hated’ for a reason
… to advance that idea, with Republican majorities in Congress and conservative Tom Price as head of the Department of Health and Human Services. But Trump, known for his populist appeal, may push for other measure putting downward pressure on …
Drug company exec: ‘We’re hated’ for a reason
… to advance that idea, with Republican majorities in Congress and conservative Tom Price as head of the Department of Health and Human Services. But Trump, known for his populist appeal, may push for other measure putting downward pressure on …
Drug company exec: ‘We’re hated’ for a reason
… to advance that idea, with Republican majorities in Congress and conservative Tom Price as head of the Department of Health and Human Services. But Trump, known for his populist appeal, may push for other measure putting downward pressure on …
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Pfizer
Sales of Regeneron’s lead product have been tapering off, but a handful of potential blockbusters could provide some big gains in 2017 and beyond. The pharma giant, meanwhile, also has some exciting growth drivers in its lineup, but an aging product line will make big gains difficult going forward.
Sanofi, Regeneron cholesterol drug barred by judge
… and belong to a new, powerful class of cholesterol fighters known as PCSK9s. Their sales have proven disappointing as health insurers have resisted paying the high prices, though analysts expect the drugs will eventually be big sellers. RBC Capital …